Status:

UNKNOWN

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy

Lead Sponsor:

Fuzhou General Hospital

Conditions:

Kidney Transplant

Chronic Allograft Nephropathy

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

PHASE2

Brief Summary

Mesenchymal Stem Cell (MSC) have been shown to have immunosuppressive and repairing properties. the investigators will infuse expanded MSC into patients who develop Chronic Allograft Nephropathy. The ...

Detailed Description

Kidney transplantation is a common procedure in hospitals, but organ rejection and chronic nephrotoxicity are potential problems for the patient. Approximately ninety percent of the protocol biopsies ...

Eligibility Criteria

Inclusion

  • Recipients of a renal allograft, Male and female patients age 18 to 60 years of age.
  • Ability to provide written informed consent.
  • The serum creatinine form 176umol/L(2mg/ml) to 440umol/L(5mg/ml)
  • Renal biopsy Criteria: chronic allograft nephropathy (Banff I-II).
  • Immunosuppressant:CNI and MMF and Sirolimus
  • Written informed consent, compliant with local regulations.

Exclusion

  • Recipients with leucopenia (WBC \< 3000/mm³), thrombocytopenia (Thr \< 100.000/mm³),or hyperlipidemia (Tot Chol \> 300 mg/dl or Triglycerides \> 300 mg/dl).
  • Recipients of multiple organs.
  • Pregnant women.
  • Previous history of malignancy
  • Active infection including hepatitis B, hepatitis C, HIV, or TB as determined by a positive skin test or clinical presentation, or under treatment for suspected TB.
  • Evidence of cardiovascular disease, existing congestive cardiac failure on physical exam and/or acute coronary syndrome in past 6 months.
  • Inadequate compliance to treatment.

Key Trial Info

Start Date :

May 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2010

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT00659620

Start Date

May 1 2008

End Date

May 1 2010

Last Update

April 16 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fuzhou General Hospital

Fuzhou, Fujian, China, 350025

Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy | DecenTrialz